Results 11 to 20 of about 94,325 (274)

Dry eye syndrome in thyroid-associated ophthalmopathy

Oftalʹmologiâ, 2015
Purpose: The pathogenesis of keratoconjunctivitis sicca in patients with thyroid eye disease is presented. The influence of therapy by a HYLO-PARIN® on a condition of a tear film in patients with various forms of thyroid eye disease is assessed. Methods:
A. F. Brovkina, O. N. Steshenko, O. D. Zhukova   +2 more
doaj   +3 more sources

Identification of optimal surgical plan for treatment of extraocular muscle damage in thyroid eye disease patients based on computational biomechanics

Frontiers in Bioengineering and Biotechnology, 2023
This study replicated the behavior of intraorbital tissue in patients with thyroid eye disease (TED) based on finite element analysis for general orbital decompression risk evaluation in thyroid eye disease patients. The orbit and intraorbital tissues of
Byeong Cheol Jeong, Chiseung Lee, Chiseung Lee, Chiseung Lee, Jungyul Park, Jungyul Park, Dongman Ryu   +6 more
doaj   +1 more source

Thyroid Eye Disease

Shah SS, Stokkermans TJ, Patel BC.
europepmc   +4 more sources

Thyroid eye disease or Graves’ orbitopathy: What name to use, and why it matters

Frontiers in Endocrinology, 2022
There is currently no universally accepted name for inflammatory disease of the eye and orbit associated with thyroid autoimmune disease. Variability in terminology impedes the evaluation of scientific literature and clinical collaboration and can affect
Lilly H. Wagner, Elizabeth A. Bradley, Andrea A. Tooley, Yanhan Ren, Kharisa N. Rachmasari, Marius N. Stan   +5 more
doaj   +1 more source

Morphometric and volumetric analysis of lacrimal glands in patients with thyroid eye disease

Scientific Reports, 2023
Assessment of morphometric and volumetric changes in lacrimal glands in thyroid eye disease, its clinical manifestations in relation of disease progression.
Ana Starčević, Zoran Radojičić, Aleksandra Djurić Stefanović, Aleksandar Trivić, Ivan Milić, Marina Milić, Dragan Matić, Jovana Andrejic, Vuk Djulejic, Igor Djoric   +9 more
doaj   +1 more source

Intraocular pressure improvement in patients receiving teprotumumab for the treatment of thyroid eye disease: a case series

Journal of Medical Case Reports, 2022
Background Teprotumumab is a novel treatment that reduces inflammation and symptoms caused by thyroid eye disease. There are limited data on teprotumumab’s effect on intraocular pressure.
Matthew Chu, Jonathan Sung, Michael Song, Alice Song, Julia Song   +4 more
doaj   +1 more source

Axial Globe Position Measurement: A Prospective Multicenter Study by the International Thyroid Eye Disease Society [PDF]

, 2016
Identify a reproducible measure of axial globe position (AGP) for multicenter studies on patients with thyroid eye disease (TED)
Bingham, Chad M, Davies, Brett W, Devoto, Martin H, Durairaj, Vikram D, ELEFANTE, ANDREA, Fay, Aaron, Feldon, Steve E, Fischer, William, Gurka, Matthew J, Harris, Matheson, Hogg, Jeffery P, Kazim, Michael, Looi, Audrey, Nguyen, John, Osaki, Tammy H, Realini, Tony, Saunders, Justin, Seah, Lay Leng, Shen, Sunny, Sivak Callcott, Jennifer A, STRIANESE, DIEGO, Teo, Livia, Uddin, Jimmy   +22 more
core   +1 more source

Prevalence of hyperthyroidism, hypothyroidism, and euthyroidism in thyroid eye disease: a systematic review of the literature

Systematic Reviews, 2020
Background Thyroid eye disease is an autoimmune disorder of the orbital retrobulbar tissue commonly associated with dysthyroid status. The most frequent condition is hyperthyroidism, although it is also present in hypothyroid and euthyroid patients.
Juliana Muñoz-Ortiz, Maria Camila Sierra-Cote, Estefanía Zapata-Bravo, Laura Valenzuela-Vallejo, Maria Alejandra Marin-Noriega, Pilar Uribe-Reina, Juan Pablo Terreros-Dorado, Marcela Gómez-Suarez, Karla Arteaga-Rivera, Alejandra de-la-Torre   +9 more
doaj   +1 more source

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group. [PDF]

, 2017
Cancer immunotherapy has transformed the treatment of cancer. However, increasing use of immune-based therapies, including the widely used class of agents known as immune checkpoint inhibitors, has exposed a discrete group of immune-related adverse ...
Abdallah, K., Anderson, J., Andrews, S., Arrindell, D., Ballesteros, J., Bingham, C. O., Boyer, J., Brogdon, C., Chen, D., Chonzi, D., Cotarla, I., Cunha, R., Dadu, R., Davies, M., Dawson, M., Diab, A., Dicker, Adam, Eifler, L., Ernstoff, M. S., Ferguson, A., Ferlini, C., Frankel, S., Go, W., Gochett, C., Goldberg, J., Goncalves, P., Goswami, T., Gregory, N., Gulley, J. L., Hamad, L., Hayreh, V., Helie, N., Holmes, W., Hsu, J. Y., Ibrahim, R., Kaufman, H. L., Kim, S., Lacouture, M. E., Lambotte, O., Larocca, C., LeBoeuf, N. R., Lehman, K., Lenihan, D., Ley-Acosta, S., Luke, J., McClure, J., Michelon, E., Nakamura, M., Onofrei, C., Patel, K., Piperdi, B., Puzanov, I., Rasheed, Z., Reshef, D., Riemer, J., Robert, C., Sarkeshik, M., Saylors, A., Schreiber, J., Shafer-Weaver, K., Shannon, V., Sharfman, W., Sharma, R., Sharon, E., Sherry, R., Silk, A. W., Simonson, C., Skondra, D., Suarez-Almazor, M. E., Thomas, C., Thompson, J. A., Trehu, E., Tresnan, D., Turner, M., Wang, Y., Wariabharaj, D., Waxman, I., Wiley, K., Wood, L., Zhang, L., Zheng, P.   +80 more
core   +2 more sources

Antigen receptor variable region repertoires expressed by T cells infiltrating thyroid, retroorbital, and pretibial tissue in Graves' disease [PDF]

, 1996
To date, it has remained unclear whether T cells infiltrating thyroid, retroorbital, and pretibial tissue of patients with Graves' ophthalmopathy and pretibial dermopathy represent a primary immune response that is directed against certain antigenic ...
Heufelder, Armin E., Scriba, Peter C., Wenzel, Björn E.   +2 more
core   +1 more source